Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Wire Cambodia.
Press releases published on May 28, 2025
TScan Therapeutics Announces Upcoming Presentation at the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
WALTHAM, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with …
Olema Oncology Announces Palazestrant Dose Selection and Trial-in-Progress Poster at ASCO 2025 Annual Meeting
GlobeNewswire
·
May 28, 2025
90 mg once-daily palazestrant dose selected for Part 2 of the Phase 3 OPERA-01 monotherapy trial and for the Phase 3 OPERA-02 combination trial with ribociclib OPERA-01 trial-in-progress poster to be presented on Monday, June 2 between 9:00am–12:00pm CT / …
Ocular Therapeutix™ To Close Enrollment This Week for SOL-R, its Second Registrational Trial Evaluating AXPAXLI™ in Wet Age-Related Macular Degeneration
GlobeNewswire
·
May 28, 2025
Enrollment for SOL-R, the largest retinal TKI trial to date, supports randomization of at least 555 subjects SOL-1, Ocular’s first registrational trial in wet AMD, completed randomization in December 2024 and retention remains exceptional as the trial …
Oragenics, Inc. Announces One-for-Thirty Reverse Stock Split
GlobeNewswire
·
May 28, 2025
SARASOTA, Fla., May 28, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”), a biotech company advancing innovative treatments for brain-related health conditions, today announced that its Board of Directors (the “ …
Generation Bio to Present at the 2025 Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, announced that Geoff McDonough, M.D., president and …
Velocity comes out of stealth with $10M to power the Velocity of Money
GlobeNewswire
·
May 28, 2025
London, May 28, 2025 (GLOBE NEWSWIRE) -- Velocity announces a $10M pre-seed funding round and emerges from stealth to launch the Stablecoin Payment Account. The round was led by Activant Capital, with participation from Fuel Ventures, Triton Capital, …
Y-mAbs Hosts Virtual Radiopharmaceutical R&D Update Highlighting Clinical Progress and Expanded Pipeline
GlobeNewswire
·
May 28, 2025
Company’s Part A data readout from first-in-human Phase 1 Trial 1001 in patients with recurrent or refractory metastatic solid tumors known to express GD2, validates GD2-SADA as safe, tolerable and able to achieve targeted in vivo conjugation of 177Lu-DOTA …
Veru Reports Positive Safety Results from Phase 2b QUALITY Study: Enobosarm Added to Semaglutide Led to Greater Fat Loss, Preservation of Muscle, and Fewer Gastrointestinal Side Effects Compared to Semaglutide Alone
GlobeNewswire
·
May 28, 2025
--Phase 2b QUALITY clinical study topline safety data shows that the enobosarm + semaglutide combination had a positive safety profile compared to semaglutide alone-- --Based on Phase 2b QUALITY trial efficacy and safety data, enobosarm 3mg will advance as …
Alvotech and Advanz Pharma Extend Strategic Partnership to Commercialize Three Additional Biosimilars in Europe
GlobeNewswire
·
May 28, 2025
Advanz Pharma secures exclusive rights from Alvotech to commercialize three biosimilar candidates in Europe in addition to previously partnered programs The agreement includes proposed biosimilars to Ilaris® (canakinumab), Kesimpta® (ofatumumab) and an …
Jiayin Group Inc. to Release First Quarter 2025 Unaudited Financial Results on Wednesday, June 4, 2025
GlobeNewswire
·
May 28, 2025
SHANGHAI, China, May 28, 2025 (GLOBE NEWSWIRE) -- Jiayin Group Inc. (“Jiayin” or the “Company”) (NASDAQ: JFIN), a leading fintech platform in China, today announced that it will release its unaudited financial results for the first quarter of 2025 before …
Acronis Appoints Eduardo García Sancho as Iberia Country Manager
GlobeNewswire
·
May 28, 2025
MADRID, May 28, 2025 (GLOBE NEWSWIRE) -- Acronis, a global leader in cybersecurity and data protection, is pleased to announce the appointment of Eduardo García Sancho as Iberia Country Manager. In this role, García Sancho will lead the regional team in …
Acronis nombra a Eduardo García Sancho como Country Manager para Iberia
GlobeNewswire
·
May 28, 2025
MADRID, May 28, 2025 (GLOBE NEWSWIRE) -- Acronis, líder global en ciberseguridad y protección de datos, ha anunciado el nombramiento de Eduardo García Sancho como Country Manager para Iberia. En este cargo, García Sancho liderará al equipo regional para …
UK businesses race to embed AI into enterprise workflows, EXL study finds
GlobeNewswire
·
May 28, 2025
LONDON, May 28, 2025 (GLOBE NEWSWIRE) -- Businesses in the UK are making significant changes in the ways they work as they increasingly embed AI throughout their workflows and to scale and maximise ROI, according to new research by EXL [NASDAQ: EXLS], a …
Johannesburg Gets Ready for Digital Finance Africa 2025
GlobeNewswire
·
May 28, 2025
IT News Africa’s Digital Finance Africa 2025 drives fintech innovation, secure cross-border payments, AI advancements, and financial inclusion across Africa. JOHANNESBURG, May 28, 2025 (GLOBE NEWSWIRE) -- Africa is undergoing a profound financial …
ADVANT Nctm Selects iManage to Power Flexible, Secure Document and Email Management Across Global Legal Practice
GlobeNewswire
·
May 28, 2025
CHICAGO, May 28, 2025 (GLOBE NEWSWIRE) -- iManage, the company dedicated to Making Knowledge Work™, today announced that ADVANT Nctm, one of Italy’s leading independent law firms, has selected iManage to transform its approach to document and email …
DEBRA Research and Dermaliq Enter into a Strategic Collaboration to Advance Cutaneous Drug Delivery for Epidermolysis Bullosa
GlobeNewswire
·
May 28, 2025
Initial programs will focus on developing innovative topical treatments and drug therapies for wound healing and itch relief, plus prophylactic therapies for people with Epidermolysis Bullosa. Dermaliq’s proprietary hyliQ® technology platform enables …
NANOBIOTIX to Participate in the Jefferies Global Healthcare Investor Conference
GlobeNewswire
·
May 28, 2025
PARIS and CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering nanoparticle-based approaches to expand treatment possibilities for patients …
NANOBIOTIX participera à la conférence investisseurs annuelle Jefferies Global Healthcare
GlobeNewswire
·
May 28, 2025
PARIS et CAMBRIDGE, Mass., 28 mai 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO –– NASDAQ : NBTX – la « Société »), société française de biotechnologie en phase de développement clinique avancé, pionnière des approches fondées sur les nanoparticules …
Azerion publishes Interim Unaudited Financial Results Q1 2025
GlobeNewswire
·
May 28, 2025
Quarterly Report Q1 2025 .. 4th consecutive Q1 Year-on-Year growth Highlights of Q1 Throughout Q1 2025 we have continued our multi-year focus on efficiency and profitability; favouring long-term economic decisions over short-term opportunities. We have …
InflaRx Announces Outcome of Interim Analysis for Vilobelimab Phase 3 Trial in Pyoderma Gangrenosum
GlobeNewswire
·
May 28, 2025
JENA, Germany, May 28, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced that the Independent Data Monitoring Committee (IDMC) …